trial summary · NCT07812233
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
Trial record from the TrialBase DB dataset, status RECRUITING, condition Autism Spectrum Disorder, sponsored by Massachusetts General Hospital. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Heart rate variability biofeedback (HRVB) is a breathing-based intervention that reduces anxiety in a range of populations. Second-generation wearable HRVB devices not only deliver scheduled biofeedback practice sessions but also allow patients to practice HRVB in-the-moment when it is needed most. This study is testing the acceptability, feasibility, and preliminary efficacy of second-generation, ambulatory HRVB for the treatment of anxiety in autistic youth.
Source record: https://clinicaltrials.gov/study/NCT07812233
Facts
| registry id | NCT07812233 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | Autism Spectrum Disorder |
| sponsor | Massachusetts General Hospital |
| sponsor class | OTHER |
| enrollment | 50 |
| start date | 2026-10-26 |
| primary completion | 2029-05 |
| completion | 2029-05 |
| results posted | not reported |
Conditions
- Autism Spectrum Disorder
- Anxiety
Interventions
- Lief Smart Patch
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.